News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Conference News AHA 2021 No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials Todd Neale November 15, 2021
News Daily News HEP-COVID: Therapeutic-Dose Heparin Effective in Non-ICU Patients Yael L. Maxwell October 12, 2021
News Daily News Score May Help Guide VITT Management After COVID-19 Vaccination Todd Neale September 23, 2021
News Daily News Largest Study of VITT After COVID-19 Vaccination Digs Into Lab, Clinical Features Todd Neale August 11, 2021
News Daily News Rare Clotting Complication Seen After mRNA Vaccine: Case Report Caitlin E. Cox June 28, 2021
News Daily News CVST Risk Far Lower With Viral-Vector Vaccines Than With COVID-19 Itself Todd Neale June 10, 2021
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Conference News SCAI 2021 Compression Times Cut With Adjunctive Hemostatic Patch After Transradial Procedures Michael O'Riordan May 03, 2021
News Daily News AHA/ASA Offers Advice on Rare Blood Clots Seen After Vaccines for COVID-19 Todd Neale April 30, 2021
News Daily News Blood Clots After COVID-19 Vaccination Linked to Immune Response: UK Report Michael O'Riordan April 16, 2021
News Daily News Prophylactic Anticoagulation, Fewer Deaths in Hospitalized COVID-19 Patients Michael O'Riordan February 15, 2021
News Features The Right Anticoagulation Dose in COVID-19? Final Answer Remains Elusive Todd Neale February 08, 2021